Search
01/11/2021
Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study
Arab, JP, Diaz, LA, Baeza, N, Idalsoaga, F, Fuentes-Lopez, E, Arnold, J, Ramirez, CA, Morales-Arraez, D, Ventura-Cots, M, Alvarado-Tapias, E, Zhang, W, Clark, V, Simonetto, D, Ahn, JC, Buryska, S, Mehta, TI, Stefanescu, H, Horhat, A, Bumbu, A, Dunn, W, Attar, B, Agrawal, R, Haque, ZS, Majeed, M, Cabezas, J, Garcia-Carrera, I, Parker, R, Cuyas, B, Poca, M, Soriano, G, Sarin, SK, Maiwall, R, Jalal, PK, Abdulsada, S, Higuera-de la Tijera, MF, Kulkarni, AV, Rao, PN, Salazar, PG, Skladany, L, Bystrianska, N, Prado, V, Clemente-Sanchez, A, Rincon, D, Haider, T, Chacko, KR, Cairo, F, Coelho, MD, Romero, GA, Pollarsky, FD, Restrepo, JC, Castro-Sanchez, S, Toro, LG, Yaquich, P, Mendizabal, M, Garrido, ML, Narvaez, A, Bessone, F, Marcelo, JS, Piombino, D, Dirchwolf, M, Arancibia, JP, Altamirano, J, Kim, W, Araujo, RC, Rojo, AD, Vargas, V, Rautou, PE, Issoufaly, T, Zamarripa, F, Torre, A, Lucey, MR, Mathurin, P, Louvet, A, Garcia-Tsao, G, Gonzalez, JA, Verna, E, Brown, RS, Roblero, JP, Abraldes, JG, Arrese, M, Shah, VH, Kamath, PS, Singal, AK, Bataller, R. Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study. JOURNAL OF HEPATOLOGY. 2021; 75(5)DOI:10.1016/j.jhep.2021.06.019. PMID:34166722. IF:30.083(Q1/1D).
01/11/2021
Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry
Chaparro, M, Garre, A, Iborra, M, Sierra-Ausin, M, Barreiro-de Acosta, M, Fernandez-Clotet, A, de Castro, L, Bosca-Watts, M, Casanova, MJ, Lopez-Garcia, A, Lorente, R, Rodriguez, C, Carbajo, AY, Arroyo, MT, Gutierrez, A, Hinojosa, J, Martinez-Perez, T, Villoria, A, Bermejo, F, Busquets, D, Camps, B, Canete, F, Mancenido, N, Monfort, D, Navarro-Llavat, M, Perez-Calle, JL, Ramos, L, Rivero, M, Angueira, T, Monterde, PC, Carpio, D, Garcia-de-la-Filia, I, Gonzalez-Munoza, C, Hernandez, L, Huguet, JM, Morales, VJ, Sicilia, B, Vega, P, Vera, I, Zabana, Y, Nos, P, Alvarez, PS, Calvino-Suarez, C, Ricart, E, Hernandez, V, Minguez, M, Marquez, L, Cruz, DH, Iturria, SR, Barrio, J, Gargallo-Puyuelo, C, Frances, R, Hinojosa, E, del Moral, M, Calvet, X, Algaba, A, Aldeguer, X, Guardiola, J, Manosa, M, Pajares, R, Piqueras, M, Garcia-Bosch, O, Serrano, PL, Castro, B, Lucendo, AJ, Montoro, M, Ortiz, EC, Mesonero, F, Garcia-Planella, E, Fuentes, DA, Bort, I, Delgado-Guillena, P, Arias, L, Iglesias, A, Calvo, M, Esteve, M, Domenech, E, Gisbert, JP. Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry. Journal of Crohns & Colitis. 2021; 15(11)DOI:10.1093/ecco-jcc/jjab070. PMID:33860795. IF:10.020(Q1/2D).
01/11/2021
Effects of Albumin on Survival after a Hepatic Encephalopathy Episode: Randomized Double-Blind Trial and Meta-Analysis
Ventura-Cots, M, Simon-Talero, M, Poca, M, Ariza, X, Masnou, H, Sanchez, J, Llop, E, Canete, N, Martin-Llahi, M, Amador, A, Martinez, J, Clemente-Sanchez, A, Puente, A, Torrens, M, Alvarado-Tapias, E, Napoleone, L, Miquel-Planas, M, Ardevol, A, Rodrigo, MC, Calleja, JL, Sole, C, Soriano, G, Genesca, J. Effects of Albumin on Survival after a Hepatic Encephalopathy Episode: Randomized Double-Blind Trial and Meta-Analysis. Journal of Clinical Medicine. 2021; 10(21)DOI:10.3390/jcm10214885. PMID:34768404. IF:4.964(Q2/4D).
01/11/2021
Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study
Reig, A, Alvarez-Navascues, C, Vergara, M, Gomez-Dominguez, E, Gallego-Moya, A, Perez-Medrano, IM, Fabrega, E, Hernandez-Guerra, M, Berenguer, M, Estevez, P, Arencibia, A, Morillas, RM, Horta, D, Albillos, A, Casado, M, De la Cruz, G, Fernandez-Bonilla, E, Molina, E, Hijona, L, Diago, M, Fernandez-Rodriguez, CM, Gonzalez-Santiago, JM, Sala, M, Gomez-Camarero, J, Romero-Gomez, M, Suarez, F, Vargas, V, Ferre-Aracil, C, Andrade, RJ, Chahri, N, Pares, A. Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study. AMERICAN JOURNAL OF GASTROENTEROLOGY. 2021; 116(11)DOI:10.14309/ajg.0000000000001343. PMID:34158466. IF:12.045(Q1/1D).
01/11/2021
Growth Differentiation Factor 15 (GDF-15): A Novel Biomarker Associated with Poorer Respiratory Function in COVID-19
Alserawan, L, Penacoba, P, Echevarria, SEO, Castillo, D, Ortiz, E, Martinez-Martinez, L, Naranjo, EM, Domingo, P, Castellvi, I, Juarez, C, Mariscal, A. Growth Differentiation Factor 15 (GDF-15): A Novel Biomarker Associated with Poorer Respiratory Function in COVID-19. Diagnostics. 2021; 11(11)DOI:10.3390/diagnostics11111998. PMID:34829345. IF:3.992(Q2/4D).
01/11/2021
Standardized Comparison of Cardiovascular Risk Factors Prevalence in Spanish Women and Men Living with HIV and in the General Population
Camps-Vilaro, A, Perez-Fernandez, S, Subirana, I, Teira, R, Estrada, V, Domingo, P, Degano, IR, Marrugat, J. Standardized Comparison of Cardiovascular Risk Factors Prevalence in Spanish Women and Men Living with HIV and in the General Population. Journal of Personalized Medicine. 2021; 11(11)DOI:10.3390/jpm11111085. PMID:34834438. IF:3.508(Q2/4D).
01/11/2021
Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study
Nomah, DK, Reyes-Uruena, J, Diaz, Y, Moreno, S, Aceiton, J, Bruguera, A, Vivanco-Hidalgo, RM, Llibre, JM, Domingo, P, Falco, V, Imaz, A, Cortes, C, Force, L, Letang, E, Vilaro, I, Casabona, J, Miro, JM, Mur I., Macorigh, Lizza. Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study. Lancet HIV. 2021; 8(11)DOI:10.1016/S2352-3018(21)00240-X. PMID:34655549. IF:16.070(Q1/1D).
01/11/2021
Antibiotic-exposed patients with non-small-cell lung cancer preserve efficacy outcomes following first-line chemo-immunotherapy
Cortellini, A, Ricciuti, B, Facchinetti, F, Alessi, JVM, Venkatraman, D, Dall'Olio, FG, Cravero, P, Vaz, VR, Ottaviani, D, Majem, M, Piedra, A, Sullivan, I, Lee, KA, Lamberti, G, Hussain, N, Clark, J, Bolina, A, Barba, A, Benitez, JC, Gorria, T, Mezquita, L, Hoton, D, Nana, FA, Besse, B, Awad, MM, Pinato, DJ. Antibiotic-exposed patients with non-small-cell lung cancer preserve efficacy outcomes following first-line chemo-immunotherapy. ANNALS OF ONCOLOGY. 2021; 32(11)DOI:10.1016/j.annonc.2021.08.1744. PMID:34400292. IF:51.769(Q1/1D).
01/11/2021
Paired Somatic-Germline Testing of 15 Polyposis and Colorectal Cancer-Predisposing Genes Highlights the Role of APC Mosaicism in de Novo Familial Adenomatous Polyposis
Rofes, P, Gonzalez, S, Navarro, M, Moreno-Cabrera, JM, Solanes, A, Darder, E, Carrasco, E, Iglesias, S, Salinas, M, Gomez, C, Velasco, A, Tuset, N, Varela, M, Llort, G, Cajal, TRY, Grau, E, Duenas, N, Merlano, ND, Matias-Guiu, X, Rivera, B, Balmana, J, Pineda, M, Brunet, J, Capella, G, del Valle, J, Lazaro, C. Paired Somatic-Germline Testing of 15 Polyposis and Colorectal Cancer-Predisposing Genes Highlights the Role of APC Mosaicism in de Novo Familial Adenomatous Polyposis. JOURNAL OF MOLECULAR DIAGNOSTICS. 2021; 23(11)DOI:10.1016/j.jmoldx.2021.07.024. PMID:34454113. IF:5.341(Q1/3D).
01/11/2021
Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
Gronchi, A, Miah, AB, DeiTos, AP, Abecassis, N, Bajpai, J, Bauer, S, Biagini, R, Bielack, S, Blay, JY, Bolle, S, Bonvalot, S, Boukovinas, I, Bovee, JVMG, Boye, K, Brennan, B, Brodowicz, T, Buonadonna, A, DeAlava, E, Del Muro, XG, Dufresne, A, Eriksson, M, Fagioli, F, Fedenko, A, Ferraresi, V, Ferrari, A, Frezza, AM, Gasperoni, S, Gelderblom, H, Gouin, F, Grignani, G, Haas, R, Hassan, AB, Hecker-Nolting, S, Hindi, N, Hohenberger, P, Joensuu, H, Jones, RL, Jungels, C, Jutte, P, Kager, L, Kasper, B, Kawai, A, Kopeckova, K, Krakorova, DA, Le Cesne, A, LeGrange, F, Legius, E, Leithner, A, Lopez-Pousa, A, Martin-Broto, J, Merimsky, O, Messiou, C, Mir, O, Montemurro, M, Morland, B, Morosi, C, Palmerini, E, Pantaleo, MA, Piana, R, Piperno-Neumann, S, Reichardt, P, Rutkowski, P, Safwat, AA, Sangalli, C, Sbaraglia, M, Scheipl, S, Schoffski, P, Sleijfer, S, Strauss, D, Strauss, S, SundbyHall, K, Trama, A, Unk, M, VandeSande, MAJ, VanderGraaf, WTA, van Houdt, WJ, Frebourg, T, Casali, PG, Stacchiotti, S, ESMO Guidelines Comm, EURACAN, GENTURIS. Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up. ANNALS OF ONCOLOGY. 2021; 32(11)DOI:10.1016/j.annonc.2021.07.006. PMID:34303806. IF:51.769(Q1/1D).
01/11/2021
The impact of radiological assessment schedules on progression-free survival in metastatic breast cancer: A systemic review and meta-analysis
Dabush, DR, Shepshelovich, D, Shochat, T, Tibau, A, Amir, E, Goldvaser, H. The impact of radiological assessment schedules on progression-free survival in metastatic breast cancer: A systemic review and meta-analysis. CANCER TREATMENT REVIEWS. 2021; 100DOI:10.1016/j.ctrv.2021.102293. PMID:34543860. IF:13.608(Q1/1D).
01/11/2021
Pretreatment Tissue TCR Repertoire Evenness Is Associated with Complete Pathologic Response in Patients with NSCLC Receiving Neoadjuvant Chemoimmunotherapy
Casarrubios, M, Cruz-Bermudez, A, Nadal, E, Insa, A, Campelo, MDG, Lazaro, M, Domine, M, Majem, M, Rodriguez-Abreu, D, Martinez-Marti, A, de Castro-Carpeno, J, Cobo, M, Lopez-Vivanco, G, Del Barco, E, Caro, RB, Vinolas, N, Aranda, IB, Viteri, S, Massuti, B, Barquin, M, Laza-Briviesca, R, Sierra-Rodero, B, Parra, ER, Sanchez-Espiridion, B, Rocha, P, Kadara, H, Wistuba, II, Romero, A, Calvo, V, Provencio, M. Pretreatment Tissue TCR Repertoire Evenness Is Associated with Complete Pathologic Response in Patients with NSCLC Receiving Neoadjuvant Chemoimmunotherapy. CLINICAL CANCER RESEARCH. 2021; 27(21)DOI:10.1158/1078-0432.CCR-21-1200. PMID:34376534. IF:13.801(Q1/1D).
01/11/2021
A plain language summary of results from the ADAURA study: osimertinib after surgery for patients who have early-stage EGFR-mutated non-small cell lung cancer
Wu, YL, Tsuboi, M, John, T, Grohe, C, Majem, M, Goldman, JW, Laktionov, K, Kim, SW, Kato, T, Vu, HV, Lu, S, Lee, KY, Akewanlop, C, Yu, CJ, de Marinis, F, Bonanno, L, Domine, M, Shepherd, FA, Zeng, LM, Hodge, R, Atasoy, A, Rukazenkov, Y, Herbst, RS. A plain language summary of results from the ADAURA study: osimertinib after surgery for patients who have early-stage EGFR-mutated non-small cell lung cancer. Future Oncology. 2021; 17(35)DOI:10.2217/fon-2021-0752. PMID:34723634. IF:3.674(Q3/7D).
01/11/2021
A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study
Bancroft, EK, Page, EC, Brook, MN, Thomas, S, Taylor, N, Pope, J, McHugh, J, Jones, AB, Karlsson, Q, Merson, S, Ong, KR, Hoffman, J, Huber, C, Maehle, L, Grindedal, EM, Stormorken, A, Evans, DG, Rothwell, J, Lalloo, F, Brady, AF, Bartlett, M, Snape, K, Hanson, H, James, P, McKinley, J, Mascarenhas, L, Syngal, S, Ukaegbu, C, Side, L, Thomas, T, Barwell, J, Teixeira, MR, Izatt, L, Suri, M, Macrae, FA, Poplawski, N, Chen-Shtoyerman, R, Ahmed, M, Musgrave, H, Nicolai, N, Greenhalgh, L, Brewer, C, Pachter, N, Spigelman, AD, Azzabi, A, Helfand, BT, Halliday, D, Buys, S, Cajal, TRY, Donaldson, A, Cooney, KA, Harris, M, McGrath, J, Davidson, R, Taylor, A, Cooke, P, Myhill, K, Hogben, M, Aaronson, NK, Ardern-Jones, A, Bangma, CH, Castro, E, Dearnaley, D, Dias, A, Dudderidge, T, Eccles, DM, Green, K, Eyfjord, J, Falconer, A, Foster, CS, Gronberg, H, Hamdy, FC, Johannsson, O, Khoo, V, Lilja, H, Lindeman, GJ, Lubinski, J, Axcrona, K, Mikropoulos, C, Mitra, AV, Moynihan, C, Raghallaigh, HN, Rennert, G, Collier, R, Offman, J, Kote-Jarai, Z, Eeles, RA. A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study. LANCET ONCOLOGY. 2021; 22(11)DOI:10.1016/S1470-2045(21)00522-2. PMID:34678156. IF:54.433(Q1/1D).
01/11/2021
Weight Gain and the Risk of Ovarian Cancer in BRCA1 and BRCA2 Mutation Carriers
Kim, SJ, Lubinski, J, Huzarski, T, Moller, P, Armel, S, Karlan, BY, Senter, L, Eisen, A, Foulkes, WD, Singer, CF, Tung, N, Bordeleau, L, Neuhausen, SL, Olopade, OI, Eng, C, Weitzel, JN, Fruscio, R, Narod, SA, Kotsopoulos, J, Cajal, T.R., Trister, Rachel. Weight Gain and the Risk of Ovarian Cancer in BRCA1 and BRCA2 Mutation Carriers. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2021; 30(11)DOI:10.1158/1055-9965.EPI-21-0296. PMID:34426412. IF:4.090(Q2/4D).
01/11/2021
Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up ?
Strauss S.J., Frezza A.M., Abecassis N., Bajpai J., Bauer S., Biagini R., Bielack S., Blay J.Y., Bolle S., Bonvalot S., Boukovinas I., Bovee J.V.M.G., Boye K., Brennan B., Brodowicz T., Buonadonna A., de Álava E., Dei Tos A.P., Garcia del Muro X., Dufresne A., Eriksson M., Fagioli F., Fedenko A., Ferraresi V., Ferrari A., Gaspar N., Gasperoni S., Gelderblom H., Gouin F., Grignani G., Gronchi A., Haas R., Hassan A.B., Hecker-Nolting S., Hindi N., Hohenberger P., Joensuu H., Jones R.L., Jungels C., Jutte P., Kager L., Kasper B., Kawai A., Kopeckova K., Krákorová D.A., Le Cesne A., Le Grange F., Legius E., Leithner A., López Pousa A., Martin-Broto J., Merimsky O., Messiou C., Miah A.B., Mir O., Montemurro M., Morland B., Morosi C., Palmerini E., Pantaleo M.A., Piana R., Piperno-Neumann S., Reichardt P., Rutkowski P., Safwat A.A., Sangalli C., Sbaraglia M., Scheipl S., Schöffski P., Sleijfer S., Strauss D., Sundby Hall K., Trama A., Unk M., van de Sande M.A.J., van der Graaf W.T.A., van Houdt W.J., Frebourg T., Ladenstein R., Casali P.G., Stacchiotti S., EURACAN, GENTURIS and ERN PaedCan. Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up ?. ANNALS OF ONCOLOGY. 2021; 32(12)DOI:10.1016/j.annonc.2021.08.1995. PMID:34500044. IF:51.769(Q1/1D).
01/11/2021
Antibacterial Activity of T22, a Specific Peptidic Ligand of the Tumoral Marker CXCR4
Serna, N, Carratala, JV, Conchillo-Sole, O, Martinez-Torro, C, Unzueta, U, Mangues, R, Ferrer-Miralles, N, Daura, X, Vazquez, E, Villaverde, A. Antibacterial Activity of T22, a Specific Peptidic Ligand of the Tumoral Marker CXCR4. Pharmaceutics. 2021; 13(11)DOI:10.3390/pharmaceutics13111922. PMID:34834337. IF:6.525(Q1/2D).
01/11/2021
Anatomic mapping of the collateral branches of the external carotid artery with regard to daily clinical practice
Cobiella, R, Quinones, S, Aragones, P, Leon, X, Abramovic, A, Vazquez, T, Sanudo, JR, Maranillo, E, Olewnik, L, de Blas, CS, Parkin, I, Konschake, M. Anatomic mapping of the collateral branches of the external carotid artery with regard to daily clinical practice. ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER. 2021; 238DOI:10.1016/j.aanat.2021.151789. PMID:34214605. IF:2.976(Q1/2D).
01/11/2021
Salvage carbon dioxide transoral laser microsurgery for laryngeal cancer after (chemo)radiotherapy: a European Laryngological Society consensus statement
Piazza, C, Paderno, A, Sjogren, EV, Bradley, PJ, Eckel, HE, Makitie, A, Matar, N, Paleri, V, Peretti, G, Puxeddu, R, Quer, M, Remacle, M, Vander Poorten, V, Vilaseca, I, Simo, R. Salvage carbon dioxide transoral laser microsurgery for laryngeal cancer after (chemo)radiotherapy: a European Laryngological Society consensus statement. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY. 2021; 278(11)DOI:10.1007/s00405-021-06957-5. PMID:34226992. IF:3.236(Q2/3D).
01/11/2021
Differential characteristics of patients with squamous cell carcinoma of the head and neck according to gender
Leon, X, Garcia, J, Lopez, M, Holgado, A, Llansana, A, Quer, M. Differential characteristics of patients with squamous cell carcinoma of the head and neck according to gender. Acta Otorrinolaringologica Espanola. 2021; 72(6)DOI:10.1016/j.otorri.2020.08.009. PMID:33618830. IF:(Q/D).